TAPEESH KANSAL: Open Payments
NPI 1841291408 · SAN BERNARDINO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$912 in 40 payments from 6 companies in 2025. Trend: 2023 $586 · 2024 $571 · 2025 $912
Food & beverage: $912
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 12 | $314 |
| Teva Pharmaceuticals USA, Inc. | 13 | $222 |
| Neurocrine BioSciences, Inc. | 9 | $161 |
| ABBVIE INC. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Otsuka America Pharmaceutical, Inc. | 3 | $43 |
Products named: ARISTADA, AUSTEDO XR, INGREZZA, VRAYLAR, LYBALVI, COBENFY, UZEDY, ABILIFY ASIMTUFII.
Industry payments across CA — which companies pay providers there.
